Wall motion changes in myocardial infarction in relation to the time elapsed from symptoms until revascularization

Ildikó Rácz1, László Fülöp, Rudolf Kolozsvári

  • 1Institute of Cardiology and Heart Surgery, University of Debrecen Clinical Center; Debrecen-Hungary. iracz73@gmail.com.

Insights

Wall motion abnormalities in ST-segment elevation myocardial infarction (STEMI) vary initially but improve with shorter ischemic times. Early intervention is key for better left ventricular function recovery after primary PCI.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Interventional Cardiology

Background:

  • Acute ST-segment elevation myocardial infarction (STEMI) causes wall motion abnormalities.
  • The extent of these abnormalities and their recovery post-recanalization are influenced by coronary occlusion.
  • Understanding these dynamics is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To investigate the relationship between ischemic time and left ventricular wall motion abnormalities in STEMI patients.
  • To assess the impact of ischemic time on functional recovery after primary percutaneous coronary intervention (PCI).

Main Methods:

  • Evaluated 57 STEMI patients with one-artery occlusion treated with primary PCI.
  • Used coronary angiography and echocardiography to assess the area at risk and wall motion abnormalities.
  • Compared these findings with elapsed time from symptom onset and at 3-month follow-up.

Main Results:

  • No correlation between initial wall motion index and symptom onset time.
  • Improvement in wall motion abnormalities at follow-up was dependent on ischemic time (r=-0.29, p<0.03).
  • Early STEMI subgroup showed improved ejection fraction; late subgroup had increased ventricular diameters.

Conclusions:

  • Initial wall motion abnormalities in STEMI show variability unrelated to symptom onset time.
  • Follow-up echocardiography demonstrates that functional recovery is significantly influenced by ischemic time.
  • Shorter ischemic times are associated with better wall motion improvement post-PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
484
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
813
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K